Basal Cell Carcinoma

Superficial curettage plus imiquimod cream 5% in the treatment of nodular basal cell carcinoma showed more treatment failure at 5 years vs. surgical excision, according to a study.

A phase 3 study of Ameluz and RhodoLED photodynamic therapy for superficial basal cell carcinoma has reached a key milestone as the final patient has completed the 1-year follow-up visit, Biofrontera announced in a press release.

Metformin may have potential in preventing nonmelanoma skin cancer, including in most populations with skin of color, according to a study.

Patients who used dupilumab for atopic dermatitis had significantly lower risks for internal malignancies than patients using other therapies, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

The FDA has cleared AIV001 for testing for the treatment of facial skin with superficial and nodular superficial basal cell carcinoma, according to an AiViva Biopharma press release.

The first patient has been enrolled in a phase 2 clinical trial of D-MNA for the treatment of basal cell carcinoma, Medicus Pharma announced in a press release.

The Dermatology Association of Radiation Therapy has announced new guidelines for the treatment of nonmelanoma skin cancer, according to an association press release.

SAN DIEGO — Basal cell carcinoma treatment with jet injection of photodynamic therapy was well tolerated by patients in a pilot study, according to a poster presentation at the American Academy of Dermatology Annual Meeting.

The phase 2 clinical trial of Verrica’s peptide-based immunotherapy trial for basal cell carcinoma has enrolled and dosed its final patient, the company announced in a press release.

Early data from a phase 1/2 trial showed promising results for AIV001, AiViva Biopharma’s intradermal basal cell carcinoma treatment, according to a company press release.